Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $45,312 - $59,506
470 Added 11.02%
4,736 $489,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $30,573 - $41,416
258 Added 6.44%
4,266 $518,000
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $50,194 - $72,897
370 Added 10.17%
4,008 $615,000
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $47,825 - $84,856
404 Added 12.49%
3,638 $653,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $30,462 - $50,098
-258 Reduced 7.39%
3,234 $382,000
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $59,384 - $89,531
507 Added 16.98%
3,492 $499,000
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $377,483 - $701,624
2,985 New
2,985 $514,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fund Management At Engine No. 1 LLC Portfolio

Follow Fund Management At Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.